| Activated c-Ha-ras oncogene with a guanine to thymine transversion at the twelfth codon in a human stomach cancer cell line. | gastric, |
| Expression of a transfected v-Harvey-ras oncogene in a Dunning rat prostate adenocarcinoma and the development of high metastatic ability. | prostate, |
| Ha-ras oncogene product in human gastric carcinoma: correlation with invasiveness, metastasis or prognosis. | gastric, |
| Amino-acid substitution at codon 13 of the N-ras oncogene in rectal cancer in a Japanese patient. | colorectal, |
| Modification of Ha-ras oncogene p21 expression and cell cycle progression in the human colonic cancer cell line HT-29. | colorectal, |
| Introduction of v-Ha-ras oncogene induces differentiation of cultured human medullary thyroid carcinoma cells. | thyroid, |
| Elevated expression and point mutation of the Ha-ras proto-oncogene in mouse skin tumors promoted by benzoyl peroxide and other promoting agents. | skin, |
| Epidermal papillomas and carcinomas induced in uninitiated mouse skin by tumor promoters alone contain a point mutation in the 61st codon of the Ha-ras oncogene. | skin, |
| Expression of Ha-ras oncogene products in human neuroblastomas and the significant correlation with a patient s prognosis. | neuroblastoma, |
| Activation of H-ras oncogene in rat bladder tumors induced by N-butyl-N-(4-hydroxybutyl)nitrosamine. | bladder, |
| Localization of c-Ha-ras-1 oncogene in the t(7p-;11p+) abnormality of two cases with myeloid leukemia. | leukemia, |
| [Expression of Ha-ras oncogene product, p21 in gastric carcinoma]. | gastric, |
| Malignant properties of sublines selected from a human bladder cancer cell line that contains an activated c-Ha-ras oncogene. | bladder, |
| Oncogene activation in malignant transformation: a study of H-ras in human breast cancer. | breast, |
| High frequency of rare alleles of the human c-Ha-ras-1 proto-oncogene in breast cancer patients. | breast, |
| Clustering of undermethylated CCGG and GCGC sequences in the 5 region of the Ha-ras-1 oncogene of human leukemic K562 cells. | leukemia, |
| A c-ras-Ki oncogene is activated, amplified and overexpressed in a human osteosarcoma cell line. | osteosarcoma, |
| Suppression of tumorigenicity with continued expression of the c-Ha-ras oncogene in EJ bladder carcinoma-human fibroblast hybrid cells. | bladder, |
| Del(3)(p13) in B-prolymphocytic leukemia--a new nonrandom chromosomal aberration possibly related to the c-ras oncogene. | leukemia, |
| Heparin-treated, v-myc-transformed chicken heart mesenchymal cells assume a normal morphology but are hypersensitive to epidermal growth factor (EGF) and brain fibroblast growth factor (bFGF); cells transformed by the v-Ha-ras oncogene are refractory to EGF and bFGF but are hypersensitive to insulin-like growth factors. | brain, |